PRESS RELEASE published on 02/17/2026 at 22:15, 8 months 5 days ago Voting Rights and Shares Capital of the Company Nanobiotix discloses voting rights and shares capital. The biotech company is listed on Euronext Paris and Nasdaq, focusing on disruptive therapies Euronext Paris Voting Rights Nasdaq Shares Capital NANOBIOTIX
BRIEF published on 02/02/2026 at 09:44, 8 months 21 days ago Goldman Sachs réduit sa participation dans Nanobiotix Euronext Paris Franchissement De Seuil Goldman Sachs Cession D'actions NANOBIOTIX
BRIEF published on 02/02/2026 at 09:44, 8 months 21 days ago Goldman Sachs reduces its stake in Nanobiotix Euronext Paris Goldman Sachs Threshold Crossing Transfer Of Shares NANOBIOTIX
PRESS RELEASE published on 02/02/2026 at 09:39, 8 months 21 days ago Franchissement de seuils Déclaration de franchissement de seuils par The Goldman Sachs Group, Inc. pour Nanobiotix Actions AMF Franchissement De Seuils Goldman Sachs NANOBIOTIX
BRIEF published on 01/26/2026 at 09:56, 8 months 28 days ago Franchissement de seuils par Goldman Sachs chez Nanobiotix Droits De Vote Franchissement De Seuils Goldman Sachs NANOBIOTIX Acquisition Hors Marché
BRIEF published on 01/26/2026 at 09:56, 8 months 28 days ago Goldman Sachs crosses thresholds in Nanobiotix Voting Rights Goldman Sachs Crossing Thresholds NANOBIOTIX Off-market Acquisition
PRESS RELEASE published on 01/26/2026 at 09:51, 8 months 28 days ago Franchissement de seuils Déclaration de franchissement de seuils par The Goldman Sachs Group, Inc. pour NANOBIOTIX le 19 janvier 2026 Droits De Vote Actions The Goldman Sachs Group, Inc. Franchissement De Seuils NANOBIOTIX
BRIEF published on 01/13/2026 at 22:20, 9 months 9 days ago Information mensuelle de Nanobiotix sur les actions et les droits de vote Droits De Vote Euronext Actions Nasdaq NANOBIOTIX
BRIEF published on 01/13/2026 at 22:20, 9 months 9 days ago Nanobiotix publie des informations sur ses droits de vote et son capital social. Euronext Paris Capital Social Nasdaq Droit De Vote NANOBIOTIX
BRIEF published on 01/13/2026 at 22:20, 9 months 9 days ago Nanobiotix's monthly information on shares and voting rights Voting Rights Euronext Actions Nasdaq NANOBIOTIX
Published on 10/23/2026 at 02:20, 9 hours 56 minutes ago Apex Announces Nasdaq Listing and Pricing of US$1.86 Million Offering
Published on 10/22/2026 at 23:30, 12 hours 46 minutes ago Cypher Announces Subscription Receipt Offering
Published on 10/22/2026 at 22:30, 13 hours 46 minutes ago Unusual Machines to Announce Third Quarter 2026 Financial Results and Provide Corporate Update
Published on 10/22/2026 at 16:00, 20 hours 16 minutes ago Future Fuels Announces Closing of Brokered Offering for Gross Proceeds of C$6.6 Million
Published on 10/22/2026 at 14:30, 21 hours 46 minutes ago Unusual Machines Receives $16.9 Million Purchase Order from Powerus for American-Made Drone Components
Published on 10/23/2026 at 11:45, 31 minutes ago Original-Research: Grand City Properties SA (von First Berlin Equity Research GmbH): Kaufen
Published on 10/23/2026 at 11:30, 46 minutes ago Bulgarian Financial Supervision Commission completes preliminary review of the voluntary public takeover offer for Shelly Group SE
Published on 10/23/2026 at 11:30, 46 minutes ago Acceptance period of Sazerac’s voluntary public takeover offer for Berentzen-Gruppe Aktiengesellschaft commences
Published on 10/23/2026 at 11:00, 1 hour 16 minutes ago Annual General Meeting Approves Contribution: Innok Robotics on Course for the Public Capital Market
Published on 10/23/2026 at 07:00, 5 hours 16 minutes ago Safran publie son chiffre d’affaires du 3e trimestre 2026
Published on 10/22/2026 at 18:00, 18 hours 16 minutes ago THERMADOR GROUPE : Completion of the share buy-back programme launched in August
Published on 10/22/2026 at 18:00, 18 hours 16 minutes ago THERMADOR GROUPE : Fin du programme de rachat d’actions débuté en août
Published on 10/22/2026 at 18:00, 18 hours 16 minutes ago bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics
